238 related articles for article (PubMed ID: 35921411)
21. A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.
Villani NA; Bullock G; Michaels JR; Yamato O; O'Brien DP; Mhlanga-Mutangadura T; Johnson GS; Katz ML
Mol Genet Metab; 2019 May; 127(1):107-115. PubMed ID: 31101435
[TBL] [Abstract][Full Text] [Related]
22. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.
Weimer JM; Kriscenski-Perry E; Elshatory Y; Pearce DA
Neuromolecular Med; 2002; 1(2):111-24. PubMed ID: 12025857
[TBL] [Abstract][Full Text] [Related]
23. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.
Basak I; Wicky HE; McDonald KO; Xu JB; Palmer JE; Best HL; Lefrancois S; Lee SY; Schoderboeck L; Hughes SM
Cell Mol Life Sci; 2021 May; 78(10):4735-4763. PubMed ID: 33792748
[TBL] [Abstract][Full Text] [Related]
24. CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis.
di Ronza A; Bajaj L; Sharma J; Sanagasetti D; Lotfi P; Adamski CJ; Collette J; Palmieri M; Amawi A; Popp L; Chang KT; Meschini MC; Leung HE; Segatori L; Simonati A; Sifers RN; Santorelli FM; Sardiello M
Nat Cell Biol; 2018 Dec; 20(12):1370-1377. PubMed ID: 30397314
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease.
Murray SJ; Russell KN; Melzer TR; Gray SJ; Heap SJ; Palmer DN; Mitchell NL
Exp Eye Res; 2021 Jun; 207():108600. PubMed ID: 33930398
[TBL] [Abstract][Full Text] [Related]
26. An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect.
Qureshi YH; Patel VM; Berman DE; Kothiya MJ; Neufeld JL; Vardarajan B; Tang M; Reyes-Dumeyer D; Lantigua R; Medrano M; Jiménez-Velázquez IJ; Small SA; Reitz C
Mol Cell Biol; 2018 Oct; 38(20):. PubMed ID: 30037983
[TBL] [Abstract][Full Text] [Related]
27. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.
Getty AL; Pearce DA
Cell Mol Life Sci; 2011 Feb; 68(3):453-74. PubMed ID: 20680390
[TBL] [Abstract][Full Text] [Related]
28. Cln6 mutants associated with neuronal ceroid lipofuscinosis are degraded in a proteasome-dependent manner.
Oresic K; Mueller B; Tortorella D
Biosci Rep; 2009 Jun; 29(3):173-81. PubMed ID: 18811591
[TBL] [Abstract][Full Text] [Related]
29. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
Kida E; Golabek AA; Wisniewski KE
Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
[TBL] [Abstract][Full Text] [Related]
30. A novel pathogenic frameshift variant unmasked by a large de novo deletion at 13q21.33-q31.1 in a Chinese patient with neuronal ceroid lipofuscinosis type 5.
Li W; Fan X; Zhang Y; Huang L; Jiang T; Qin Z; Su J; Luo J; Yi S; Zhang S; Shen Y
BMC Med Genet; 2020 May; 21(1):100. PubMed ID: 32393339
[TBL] [Abstract][Full Text] [Related]
31. CLN5 is cleaved by members of the SPP/SPPL family to produce a mature soluble protein.
Jules F; Sauvageau E; Dumaresq-Doiron K; Mazzaferri J; Haug-Kröper M; Fluhrer R; Costantino S; Lefrancois S
Exp Cell Res; 2017 Aug; 357(1):40-50. PubMed ID: 28442266
[TBL] [Abstract][Full Text] [Related]
32. Pathomechanisms in the neuronal ceroid lipofuscinoses.
Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162
[TBL] [Abstract][Full Text] [Related]
33. A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.
Bajaj L; Sharma J; di Ronza A; Zhang P; Eblimit A; Pal R; Roman D; Collette JR; Booth C; Chang KT; Sifers RN; Jung SY; Weimer JM; Chen R; Schekman RW; Sardiello M
J Clin Invest; 2020 Aug; 130(8):4118-4132. PubMed ID: 32597833
[TBL] [Abstract][Full Text] [Related]
34. Loss of the Batten disease gene CLN3 prevents exit from the TGN of the mannose 6-phosphate receptor.
Metcalf DJ; Calvi AA; Seaman MNj; Mitchison HM; Cutler DF
Traffic; 2008 Nov; 9(11):1905-14. PubMed ID: 18817525
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations.
Panjeshahi S; Karimzadeh P; Movafagh A; Ahmadabadi F; Rahimian E; Alijanpour S; Miryounesi M
Hum Genet; 2023 Aug; 142(8):1001-1016. PubMed ID: 37074398
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms regulating the intracellular trafficking and release of CLN5 and CTSD.
Huber RJ; Kim WD; Wilson-Smillie MLDM
Traffic; 2024 Jan; 25(1):e12925. PubMed ID: 38272448
[TBL] [Abstract][Full Text] [Related]
37. Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease).
Mitchell NL; Russell KN; Barrell GK; Tammen I; Palmer DN
Dev Neurobiol; 2023; 83(5-6):127-142. PubMed ID: 37246363
[TBL] [Abstract][Full Text] [Related]
38. Loss of
Savchenko E; Singh Y; Konttinen H; Lejavova K; Mediavilla Santos L; Grubman A; Kärkkäinen V; Keksa-Goldsteine V; Naumenko N; Tavi P; White AR; Malm T; Koistinaho J; Kanninen KM
Dis Model Mech; 2017 Sep; 10(9):1089-1100. PubMed ID: 28733362
[TBL] [Abstract][Full Text] [Related]
39. Topology and membrane anchoring of the lysosomal storage disease-related protein CLN5.
Larkin H; Ribeiro MG; Lavoie C
Hum Mutat; 2013 Dec; 34(12):1688-97. PubMed ID: 24038957
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.
Isosomppi J; Vesa J; Jalanko A; Peltonen L
Hum Mol Genet; 2002 Apr; 11(8):885-91. PubMed ID: 11971870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
